ARCHIVES

NCI Cancer Studies In China Intact; Visits Delayed

This article is from The Cancer Letter archive.

Vol. 15 No. 28 | July 14, 1989

Download PDF Visit The Full Archive

Related Articles

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982

BMS Settles Charges Of Obstructing Generics

March 14, 2003